Attenuation of RA 27-3 rubella virus in WI-38 human diploid cells.
D000328:Adult; D000362:Agar; D000917:Antibody Formation; D002460:Cell Line; D002648:Child; D002675:Child, Preschool; D046508:Culture Techniques; D004171:Diploidy; D005076:Exanthema / Q000209:etiology; D005260:Female; D005334:Fever / Q000209:etiology; D005947:Glucose; D006801:Humans; D007279:Injections, Subcutaneous; D008168:Lung; D008199:Lymphadenitis / Q000209:etiology; D008297:Male; D012409:Rubella / Q000276:immunology*; D012411:Rubella Vaccine / Q000008:administration & dosage / Q000009:adverse effects; D012412:Rubella virus / Q000302:isolation & purification / Q000472:pathogenicity; D013557:Switzerland; D014481:United States; D014556:Urine / Q000382:microbiology; D014611:Vaccination; D014765:Viral Vaccines; D014776:Virus Cultivation
D012411:Rubella Vaccine; D014765:Viral Vaccines; D000362:Agar; D005947:Glucose